Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.452, 2004-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Triptan use in France not currently ideal
Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. :
Triptan use in migraine curbed by cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :
Eletriptan efficacy for migraine not influenced by previous triptan use
Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. :
Rotavirus vaccination not currently cost effective for kids in France
Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. :
Rotavirus vaccination not currently cost effective for kids in France
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 545, 2008-01 ,pp. :